← Leaderboards
Carl J Pepine
University Of Florida
$14,456,715
Attributed
$18,896,054
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,896,054 · 8
By mechanism
R01$8,878,679 · 3
UM1$4,681,486 · 1
U01$4,575,073 · 2
N01$385,816 · 1
U09$375,000 · 1
Top collaborators
- C. Noel Bairey Merz5 shared
- Mohan K. Raizada4 shared
- Mark S. Segal4 shared
- Steven Michael Smith2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Steven Michael Smith$1,973,717
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentCellsCardiacBaseFunctional DisorderTherapeutic InterventionClinical TrialsImageTranslatingPhysiciansRecruitment ActivityNational Heart, Lung, And Blood InstituteStem CellsTherapeutic StudiesInsightReportingHeart DiseasesCardiovascular DiseasesCardiovascular SystemDoseCell PhysiologyChronicAcuteTransplantation
Grant awards (37)
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis$650,022
R01 · FY2025 · HL
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis$682,943
R01 · FY2024 · HL
Brain-Gut Microbiome-Immune Axis in Hypertension$617,909
R01 · FY2019 · HL
UFRCC for Cardiovascular Cell Therapy Research Network$689,587
UM1 · FY2018 · HL · contact PI
Brain-Gut Microbiome-Immune Axis in Hypertension$640,271
R01 · FY2018 · HL
UFRCC for Cardiovascular Cell Therapy Research Network$690,197
UM1 · FY2017 · HL · contact PI
Brain-Gut Microbiome-Immune Axis in Hypertension$665,271
R01 · FY2017 · HL
UFRCC for Cardiovascular Cell Therapy Research Network$690,331
UM1 · FY2016 · HL · contact PI
Brain-Gut Microbiome-Immune Axis in Hypertension$617,909
R01 · FY2016 · HL
UFRCC for Cardiovascular Cell Therapy Research Network$382,438
UM1 · FY2015 · HL · contact PI
UFRCC for Cardiovascular Cell Therapy Research Network$735,133
UM1 · FY2014 · HL · contact PI
UFRCC for Cardiovascular Cell Therapy Research Network$716,162
UM1 · FY2013 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$500,000
R01 · FY2013 · HL
UFRCC for Cardiovascular Cell Therapy Research Network$777,638
UM1 · FY2012 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$760,707
R01 · FY2011 · HL
Ancillary Functional Studies for the CCTRN$367,235
R01 · FY2011 · HL · contact PI
UFCC for Cardiovascular Cell Therapy Research Network$278,266
U01 · FY2011 · HL · contact PI
UFCC for Cardiovascular Cell Therapy Research Network$116,000
U01 · FY2011 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$745,442
R01 · FY2010 · HL
UFCC for Cardiovascular Cell Therapy Research Network$546,483
U01 · FY2010 · HL · contact PI
Ancillary Functional Studies for the CCTRN$367,235
R01 · FY2010 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$741,804
R01 · FY2009 · HL
UFCC for Cardiovascular Cell Therapy Research Network$552,802
U01 · FY2009 · HL · contact PI
Ancillary Functional Studies for the CCTRN$367,235
R01 · FY2009 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$775,836
R01 · FY2008 · HL
UFCC for Cardiovascular Cell Therapy Research Network$537,223
U01 · FY2008 · HL · contact PI
Ancillary Functional Studies for the CCTRN$378,860
R01 · FY2008 · HL · contact PI
UFCC for Cardiovascular Cell Therapy Research Network$546,048
U01 · FY2007 · HL · contact PI
Renin Angiotensin for Coronary Microvascular Dysfunction$364,989
U01 · FY2005 · HL
Renin Angiotensin for Coronary Microvascular Dysfunction$498,937
U01 · FY2004 · HL
Renin Angiotensin for Coronary Microvascular Dysfunction$496,035
U01 · FY2003 · HL
Renin Angiotensin for Coronary Microvascular Dysfunction$327,291
U01 · FY2002 · HL
SCIENTIFIC REVIEW AND EVALUATION GRANT$175,000
U09 · FY2002 · HL
Renin Angiotensin for Coronary Microvascular Dysfunction$310,999
U01 · FY2001 · HL
SCIENTIFIC REVIEW AND EVALUATION GRANT$200,000
U09 · FY2001 · HL
ISCHEMIC HEART DISEASE IN WOMEN--CLINICAL CENTER$0
N01 · FY2001 · HV
ISCHEMIC HEART DISEASE IN WOMEN--CLINICAL CENTER$385,816
N01 · FY2000 · HV